In the recent past, there has been an impressive growth in the number of clinical trials launched worldwide, including India. Participation in well-designed oncology clinical trials is of advantage to Indian healthcare system in general, and cancer patients in particular. However, the number of clinical trials being run in India is not commensurate with the cancer burden prevailing in the country. In this article, the authors investigate the reasons for this discrepancy, highlight critical bottlenecks, and propose ways to ameliorate the situation.

Original publication

DOI

10.4103/2278-330X.105896

Type

Journal article

Journal

South Asian J Cancer

Publication Date

01/2013

Volume

2

Pages

44 - 49

Keywords

Cancer, India, South Asia, challenges, clinical trials, delays, obstacles, oncology, regulatory, research